Paul Hartmann AG
F:PHH2

Watchlist Manager
Paul Hartmann AG Logo
Paul Hartmann AG
F:PHH2
Watchlist
Price: 225 EUR 0.9% Market Closed
Market Cap: 803.3m EUR

Wall Street
Price Targets

PHH2 Price Targets Summary
Paul Hartmann AG

There are no price targets for PHH2.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Paul Hartmann AG Competitors:
Price Targets
OMED
Jayamas Medica Industri TBK PT
10% Upside
688016
Shanghai MicroPort Endovascular MedTech Group Co Ltd
44% Upside
1501
Shanghai Kindly Medical Instruments Co Ltd
11% Upside
301101
Mingyue Optical Lens Co Ltd
50% Upside
3593
Hogy Medical Co Ltd
26% Downside
300888
Winner Medical Co Ltd
56% Upside
688253
Innovita Biological Technology Co Ltd
24% Upside
POLYMED
Poly Medicure Ltd
20% Upside

Revenue
Forecast

Revenue Estimate
Paul Hartmann AG

For the last 13 years the compound annual growth rate for Paul Hartmann AG's revenue is 2%. The projected CAGR for the next 13 years is -2%.

2%
Past Growth
-2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Paul Hartmann AG

Operating Income forecast
is not available for
Paul Hartmann AG

Net Income
Forecast

Net Income Estimate
Paul Hartmann AG

Net Income forecast
is not available for
Paul Hartmann AG
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHH2's stock price target?
Not Available

PHH2 doesn't have any price targets made by Wall Street professionals.

What is Paul Hartmann AG's Revenue forecast?
Projected CAGR
-2%

For the last 13 years the compound annual growth rate for Paul Hartmann AG's revenue is 2%. The projected CAGR for the next 13 years is -2%.

Back to Top